Maravai Lifesciences (NASDAQ:MRVI) focuses on providing reagents and products for researchers and companies developing therapeutic drugs, vaccines, and diagnostics. They specialize in nucleic acid synthesis, mRNA production for vaccine and therapeutic development, and antibody discovery. Their operations span across critical areas of life sciences and biotechnology, with an emphasis on supporting advancements in public health and innovation in the medical field. Maravai's objectives revolve around leveraging their expertise to accelerate scientific discoveries and improve patient care through the provision of high-quality, essential research materials and services.